Chronic Kidney Disease: Bridging Conventional Therapeutics and Emerging Molecular Innovations
Chronic kidney disease (CKD) is a significant public health issue worldwide, contributing to a growing burden on healthcare systems and global economies. While conventional management strategies emphasize early detection, prevention, and addressing underlying causes to slow disease progression, CKD...
Saved in:
| Main Authors: | Shao-feng Wang, Jie Gong, Hai-ying Zhang, Hao-jun Dai, Jin-jin Shi, Jing-wen Ling, Ke-qing Dong, Rosnani Hashim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
HH Publisher
2025-08-01
|
| Series: | Progress in Microbes and Molecular Biology |
| Online Access: | http://journals.hh-publisher.com/index.php/pmmb/article/view/1215 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01) -
Palmitoylation: an emerging therapeutic target bridging physiology and disease
by: Weini Li, et al.
Published: (2025-08-01) -
Vitamin D and skin disorders: bridging molecular insights to clinical innovations
by: Qing Li, et al.
Published: (2025-07-01) -
Targeting ion channel networks in diabetic kidney disease: from molecular crosstalk to precision therapeutics and clinical innovation
by: Wenfeng Wang, et al.
Published: (2025-06-01) -
The Impact of Hyperglycemic Emergencies on the Kidney and Liver
by: Feng Bai, et al.
Published: (2013-01-01)